Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GTX Inc (NASDAQ:GTXI)

0.70
Delayed Data
As of Apr 29
 -0.0001 / -0.01%
Today’s Change
0.29
Today|||52-Week Range
1.59
0.00%
Year-to-Date
No recent news for GTX Inc.

Today’s Trading

Previous close0.70
Today’s open0.71
Day’s range0.66 - 0.79
Volume29,500
Average volume (3 months)91,942
Market cap$99.2M
Dividend yield--
Data as of 3:59pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)+68.75%
Earnings growth (this year)+46.67%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book52.88

Competitors

 Today’s
change
Today’s
% change
NYMXNymox Pharmaceutical...-0.02-0.88%
DRNADicerna Pharmaceutic...-0.22-4.55%
CERUCerulean Pharma Inc-0.27-7.61%
ASMBAssembly Biosciences...+0.11+1.87%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 10, 2016
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$0.00
Annual profit (last year)-$18.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Class I Director
Marc Steven Hanover
Principal Financial &
Accounting Officer
Jason T. Shackelford
Corporate headquarters
Memphis, Tennessee

Forecasts

Partner Offers

Search for Jobs